Top Buy
| Security ▼ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Xencor Inc. | 9 | 1 | 1 | 0 | €18.70 | €31.74 | 69.727% |
| West Pharmaceutical Services Inc. | 6 | 0 | 0 | 0 | €339.10 | €369.72 | 9.031% |
| Viatris Inc. | 1 | 0 | 0 | 0 | €10.96 | - | - |
| United Therapeutics | 18 | 0 | 3 | 0 | €243.70 | €288.66 | 18.449% |
| Uniqure B.V. | 1 | 0 | 1 | 0 | €4.24 | - | - |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 4 | 0 | €39.80 | €84.74 | 112.925% |
| Tenet Healthcare | 28 | 0 | 7 | 0 | €112.00 | €121.67 | 8.631% |
| Taro Pharmaceutical Industries Ltd | 7 | 0 | 1 | 0 | €39.40 | - | - |
| Select Medical Holdings | 5 | 0 | 3 | 0 | €26.00 | €36.31 | 39.673% |
| Sartorius AG VZO | 4 | 0 | 0 | 0 | €285.40 | - | - |
| Repligen Corp. | 13 | 0 | 1 | 0 | €155.15 | €184.76 | 19.085% |
| QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| PTC Therapeutics Inc. | 14 | 5 | 3 | 0 | €31.00 | €41.51 | 33.911% |
| Perrigo Co. plc | 3 | 0 | 1 | 0 | €30.83 | €35.99 | 16.722% |
| Neurocrine Bioscience | 27 | 0 | 7 | 0 | €130.70 | €140.34 | 7.376% |
| Nektar Therapeutics | 3 | 1 | 1 | 0 | €1.46 | €3.70 | 152.732% |
| Myriad Genetics | 5 | 2 | 0 | 0 | €18.10 | €23.22 | 28.273% |
| MorphoSys AG | 7 | 0 | 0 | 0 | €66.75 | €65.00 | -2.622% |
| Molina Healthcare | 12 | 1 | 2 | 0 | €315.60 | €366.73 | 16.200% |
| Merit Medical Systems | 16 | 0 | 5 | 0 | €70.50 | €86.90 | 23.258% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €365.20 | €421.61 | 15.445% |
| Masimo Corp. | 7 | 1 | 2 | 0 | €127.05 | €147.62 | 16.187% |
| LivaNova plc | 9 | 0 | 3 | 0 | €57.00 | €66.59 | 16.829% |
| Korian S.A. | 1 | 0 | 1 | 0 | €2.39 | - | - |
| Jazz Pharmaceuticals plc | 23 | 0 | 4 | 0 | €102.25 | €184.92 | 80.851% |